Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy

Journal of the International Neuropsychological Society

Volumn 20, Issue 4, 2014, Pages 370-379

  Collins, Barbara ^a,b   MacKenzie, Joyce ^a   Tasca, Giorgio A ^a,b   Scherling, Carole ^c   Smith, Andra ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti estrogens; Longitudinal studies; Memory; Neuropsychological tests; Side effects; Verbal learning

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; BREAST NEOPLASMS; CHEMICALLY INDUCED; COGNITIVE DEFECT; DRUG EFFECTS; FEMALE; FOLLOW UP; HUMAN; INHIBITION (PSYCHOLOGY); LEARNING; MEMORY; MENTAL HEALTH; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; REACTION TIME; STATISTICS;

ADULT; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INHIBITION (PSYCHOLOGY); MEMORY; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; STATISTICS AS TOPIC; VERBAL LEARNING;

EID: 84897033550     PISSN: 13556177     EISSN: 14697661     Source Type: Journal    
DOI: 10.1017/S1355617713001215     Document Type: Conference Paper

References (52)

1. Ahles, T.A., Saykin, A.J., McDonald, B.C., Li, Y., Furstenberg, C.T., Hanscom, B.S.,yKaufman, P.A. (2010). Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. Journal of Clinical Oncology, 28, 4434-4440
2. Army Individual Test Battery. (1944). Manual of directions and scoring. Washington, DC: War Department, Adjutant General's Office
3. Beck, A.T., Steer, R.A. Brown, G.K. (1996). Beck Depression Inventory-Second Edition Manual. San Antonio, TX: Psychological Corporation
4. Bender, C.M.,Sereika,S.M., Brufsky,A.M., Ryan,C.M., Vogel, V.G., Rastogi, P., y Berga, S.L. (2007). Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause, 14, 995-998
5. Benedict, R. (1997). Brief Visuospatial Memory Test-revised professional manual. Lutz, FL: Psychological Assessment Resources
6. Brandt, J. Benedict, R. (2001). Hopkins Verbal Learning Testrevised professional manual. Lutz, FL: Psychological Assessment Resources
7. Brown, J. (1958). Some tests of the decay theory of immediate memory. Quarterly Journal of Experimental Psychology, 10, 12-21
8. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates
9. Collins, B., MacKenzie, J., Stewart, A., Bielajew, C. Verma, S. (2009a). Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment. Psychooncology, 18, 134-143
10. Collins, B., MacKenzie, J., Stewart, A., Bielajew, C. Verma, S. (2009b). Cognitive effects of hormonal therapy in early-stage breast cancer patients: A prospective study. Psychooncology, 18, 811-821
11. Collins, B., MacKenzie, J., Tasca, G.A., Scherling, C. Smith, A. (2013). Cognitive effects of chemotherapy in breast cancer patients: A dose-response study. Psychooncology, 22, 1517-1527
12. Cutter, G.R., Baier, M.L., Rudick, R.A., Cookfair, D.L., Fischer, J.S., Petkau, J.,yWilloughby, E. (1999). Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain, 122, 871-882
13. de Ruiter, M.B., Reneman, L., Boogerd, W., Veltman, D.J., Caan, M., Douaud, G., y Schagen, S.B. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping, 33, 2971-2983
14. de Ruiter, M.B., Reneman, L., Boogerd, W., Veltman, D.J., van Dam, F.S.A.M., Nederveen, A.J., y Schagen, S.B. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32, 1206-1219
15. Delis, D.C., Kaplan, E. Kramer, J.H. (2001). Delis Kaplan Executive Function System test manual. San Antonio, TX: Psychological Corporation
16. Doolittle, N.D., Korfel, A., Lubow, M.A., Schorb, E., Schlegel, U., Rogowski, S., y Neuwelt, E.A. (2013). Long-Term cognitive function, neuroimaging, and quality of life in CNS lymphoma. Neurology, 81, 84-92
17. Fischer, J.S., Jak, A.J., Kniker, J.E., Rudick, R.A. Cutter, G. (2001). Administration and scoring manual for the Multiple Sclerosis Functional Composite Measure (MSFC). New York: National Multiple Sclerosis Society
18. Gualtieri, C.T. Johnson, L.G. (2006). Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs. Archives of Clinical Neuropsychology, 21, 623-643
19. Gualtieri, C.T. Johnson, L.G. (2008). A computerized test battery sensitive to mild and severe brain injury. Medscape Journal of Medicine, 10, 90
20. Hutchinson, A.D., Hosking, J.R., Kichenadasse, G., Mattiske, J.K. Wilson, C. (2012). Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews, 38, 926-934
21. Ingraham, L.J. Aiken, C.B. (1996). An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology, 10, 120-124
22. Jansen, C.E., Cooper, B.A., Dodd, M.J. Miaskowski, A. (2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer, 19, 1647-1656
23. Jenkins, V., Shilling, V., Fallowfield, L., Howell, A. Hutton, S. (2004). Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psychooncology, 13, 61-66
24. Koppelmans, V., Breteler, M.M.B., Boogerd, W., Seynaeve, C., Gundy, C. Schagen, S.B. (2012). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30, 1080-1086
25. Koppelmans, V., de Ruiter, M.B., van Der Lijn, F., Boogerd, W., Seynaeve, C., van Der Lugt, A.,ySchagen, S.B. (2012). Global and focal brain volume in long-Term breast cancer survivors exposed to adjuvant chemotherapy. Breast Cancer Research and Treatment, 132, 1099-1106
26. Kreukels, B.P.C., Hamburger, H.L., de Ruiter, M.B., van Dam, F.S.A.M., Ridderinkhof, K.R., Boogerd, W. Schagen, S.B. (2008). ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clinical Neurophysiology, 119, 533-541
27. Kreukels, B.P.C., Schagen, S.B., Ridderinkhof, K.R., Boogerd, W., Hamburger, H.L., Muller, M.J. Van Dam, F.S.A.M. (2006). Effects of high-dose and conventional-dose adjuvant chemotherapy on long-Term cognitive sequelae in patients with breast cancer: An electrophysiologic study. Clinical Breast Cancer, 7, 67-78
28. Kreukels, B.P.C., Schagen, S.B., Ridderinkhof, K.R., Boogerd, W., Hamburger, H.L. Van Dam, F.S.A.M. (2005). Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Research and Treatment, 94, 53-61
29. Kreukels, B.P.C., van Dam, F.S.A.M., Ridderinkhof, K.R., Boogerd, W. Schagen, S.B. (2008). Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer. Clinical Breast Cancer, 8, 80-87
30. Maki, P. Hogervorst, E. (2003). HRT and cognitive decline. Best Practice and Research Clinical Endocrinology and Metabolism, 17, 105-122
31. Maki, P.M., Zonderman, A.B. Resnick, S.M. (2001). Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. American Journal of Psychiatry, 158, 227-233
32. McNair, D.M., Lorr, M.L. Droppleman, L.F. (1992). EdITS manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service
33. Nieuwenhuijsen, K., de Boer, A., Spelten, E., Sprangers, M.A. Verbeek, J.H. (2009). The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis. Psychooncology, 18, 589-597
34. Palmer, J.L., Trotter, T., Joy, A.A. Carlson, L.E. (2008). Cognitive effects of tamoxifen in premenopausal women with breast cancer compared to healthy controls. Journal of Cancer Survivorship, 2, 275-282
35. Phillips, K.A., Aldridge, J., Ribi, K., Sun, Z., Thompson, A., Harvey, V., y Bernhard, J. (2011). Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG I-98 trial. Breast Cancer Research and Treatment, 126, 221-226
36. Pullens, M.J.J., De Vries, J. Roukema, J.A. (2010). Subjective cognitive dysfunction in breast cancer patients: A systematic review. Psychooncology, 19, 1127-1138
37. Rao, S.M., Leo, G.J., Bernardin, L. Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology, 41, 685-691
38. Ryan, J., Scali, J., Carriere, I., Ritchie, K. Ancelin, M-L. (2008). Hormonal treatment, mild cognitive impairment and Alzheimer's disease. Psychogeriatrics, 20, 47-56
39. Schilder, C.M., Eggens, P.C., Seynaeve, C., Linn, S.C., Boogerd, W., Gundy, C.M., y Schagen, S.B. (2009). Neuropsychological functioning in post-menopausal breast cancer patients treated with tamoxifen or exemestane after AC chemotherapy: Cross-sectional findings from the neuropsychological TEAM-Side Study. Acta Oncologica, 48, 76-85
40. Schilder, C.M., Seynaeve, C., Beex, L.V., Boogerd, W., Linn, S.C., Gundy, C.M., y Schagen, S.B. (2010). Effects of tamoxifen and exemestane on cognitive functioning of post-menopausal patients with breast cancer: Results from the neuropsychological side study of the Tamoxifen and Exemestane Adjuvant Multinational Trial. Journal of Clinical Oncology, 28, 1294-1300
41. Shilling, V. Jenkins, V. (2007). Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. European Journal of Oncology Nursing, 11, 6-15
42. Shilling, V., Jenkins, V., Fallowfield, L. Howell, T. (2003). The effects of hormone therapy on cognition in breast cancer. Journal of Steroid Biochemistry and Molecular Biology, 86, 405-412
43. Silverman, D.H., Dy, C.J., Castellon, S.A., Lai, J., Pio, B.S., Abraham, L., y Ganz, P. (2007). Altered fronto-cortical, cerebellar and basal ganglia activity in adjuvant-Treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103, 303-311
44. Singer, J.D. Willett, J.B. (2003). Applied longitudinal data analysis: Modeling change and event occurrence. New York: Oxford University 6p
45. Vardy, J. Tannock, I. (2007). Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology, 63, 183-202
46. Walker, C.H., Drew, B.A., Antoon, J.W., Kalueff, A.V. Beckman, B.S. (2012). Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: Recent perspectives. Cancer Investigation, 30, 135-148
47. Wechsler, D. (1997). Wechsler Adult Intelligence Scale (3rd ed.). San Antonio, TX: Harcourt, Brace, Co.
48. Wefel, J.S., Lenzi, R., Theriault, R.L., Davis, R.N. Meyers, C.A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer, 100, 2292-2299
49. Wefel, J.S., Saleeba, A.K., Buzdar, A.U. Meyers, C.A. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116, 3348-3356
50. Wefel, J.S. Schagen, S.B. (2012). Chemotherapy-related cognitive dysfunction. Current Neurology and Neuroscience Reports, 12, 267-275
51. Weis, J., Poppelreuter, M. Bartsch, H.H. (2009). Cognitive deficits as long-Term side-effects of adjuvant therapy in breast cancer patients: Subjective complaints and objective neuropsychological test results. Psychooncology, 18, 775-782
52. Wolf, O.T., Kudielka, B.M., Hellhammer, D.H., Torber, S., McEwen, B.S. Kirschbaum, C. (1999). Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: Verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology, 24, 727-741.